Tissue Inhibitor of Metalloproteinase-3
"Tissue Inhibitor of Metalloproteinase-3" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A member of the family of tissue inhibitor of metalloproteinases. Mutations of the gene for TIMP3 PROTEIN causes Sorsby fundus dystrophy.
| Descriptor ID |
D019717
|
| MeSH Number(s) |
D12.776.645.875.550
|
| Concept/Terms |
Tissue Inhibitor of Metalloproteinase-3- Tissue Inhibitor of Metalloproteinase-3
- Metalloproteinase-3 Tissue Inhibitor
- Tissue Inhibitor of Metalloproteinase 3
- TIMP-3 Protein
- TIMP 3 Protein
- TIMP3 Protein
- TIMP-3
|
Below are MeSH descriptors whose meaning is more general than "Tissue Inhibitor of Metalloproteinase-3".
Below are MeSH descriptors whose meaning is more specific than "Tissue Inhibitor of Metalloproteinase-3".
This graph shows the total number of publications written about "Tissue Inhibitor of Metalloproteinase-3" by people in this website by year, and whether "Tissue Inhibitor of Metalloproteinase-3" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2003 | 0 | 1 | 1 |
| 2004 | 0 | 1 | 1 |
| 2005 | 0 | 1 | 1 |
| 2006 | 0 | 1 | 1 |
| 2007 | 1 | 0 | 1 |
| 2014 | 2 | 0 | 2 |
| 2017 | 1 | 0 | 1 |
| 2018 | 3 | 0 | 3 |
| 2020 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Tissue Inhibitor of Metalloproteinase-3" by people in Profiles.
-
Targeted Injection of a Truncated Form of Tissue Inhibitor of Metalloproteinase 3 Alters Post-Myocardial Infarction Remodeling. J Pharmacol Exp Ther. 2020 11; 375(2):296-307.
-
CDK8 Selectively Promotes the Growth of Colon Cancer Metastases in the Liver by Regulating Gene Expression of TIMP3 and Matrix Metalloproteinases. Cancer Res. 2018 12 01; 78(23):6594-6606.
-
Delivery of a matrix metalloproteinase-responsive hydrogel releasing TIMP-3 after myocardial infarction: effects on left ventricular remodeling. Am J Physiol Heart Circ Physiol. 2018 10 01; 315(4):H814-H825.
-
Iron overload: what's TIMP-3 got to do with it. Am J Physiol Heart Circ Physiol. 2018 06 01; 314(6):H1259-H1261.
-
Intracoronary delivery of recombinant TIMP-3 after myocardial infarction: effects on myocardial remodeling and function. Am J Physiol Heart Circ Physiol. 2017 Oct 01; 313(4):H690-H699.
-
Injectable and bioresponsive hydrogels for on-demand matrix metalloproteinase inhibition. Nat Mater. 2014 Jun; 13(6):653-61.
-
Local hydrogel release of recombinant TIMP-3 attenuates adverse left ventricular remodeling after experimental myocardial infarction. Sci Transl Med. 2014 Feb 12; 6(223):223ra21.
-
Oxidised, glycated LDL selectively influences tissue inhibitor of metalloproteinase-3 gene expression and protein production in human retinal capillary pericytes. Diabetologia. 2007 Oct; 50(10):2200-8.
-
Angiogenesis inhibitors in a murine neuroblastoma model: quantitative assessment of intratumoral blood flow with contrast-enhanced gray-scale US. Radiology. 2006 Jul; 240(1):73-81.
-
Trafficking of the membrane type-1 matrix metalloproteinase in ischemia and reperfusion: relation to interstitial membrane type-1 matrix metalloproteinase activity. Circulation. 2005 Mar 08; 111(9):1166-74.